Physician profile
Andrew Berman
NPI 1447240270
$2,511.61
in general payments reported to CMS, 2019-2025
21 companies · $456 in 2025
The $456 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $33.93 · 2021: $299 · 2022: $499 · 2023: $437 · 2024: $381 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,274.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $387.44 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $252.66 | 2021-2025 | Cequa |
| Allergan, INC. | $252.25 | 2019-2022 | |
| Alcon Vision LLC | $245.39 | 2019-2025 | Clareon, Tryptyr, Precision 1 |
| Amgen INC. | $234.82 | 2024-2025 | Tepezza |
| Horizon Therapeutics Plc | $231.99 | 2019-2023 | Tepezza |
| Alexion Pharmaceuticals, INC. | $231.34 | 2019-2025 | Ultomiris, Soliris |
| Bausch & Lomb Americas INC. | $105.15 | 2022-2025 | Xiidra, Miebo, Infuse |
| Abbvie INC. | $97.98 | 2022 | |
| Harrow Eye, LLC | $95.06 | 2024-2025 | Vevye |
| Oyster Point Pharma, INC. | $63.12 | 2022-2023 | Tyrvaya |
| Thea Pharma INC. | $59.99 | 2023-2025 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.69 | 2019 | |
| Shire North American Group INC | $42.59 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $34.61 | 2025 | Xdemvy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $32.04 | 2024 | Iluvien, Yutiq |
| Dompe US, INC. | $25.39 | 2024 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $23.75 | 2023 | Acuvue |
| Mallinckrodt Enterprises LLC | $20.95 | 2019 | |
| Tearlab Corp | $16.85 | 2019 | |
| Coopervision INC. | $15.55 | 2024 | Clariti Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.